Morgan Stanley lifts Henkel to “equal weight” as sales trends improve

Published 08/08/2025, 11:24
© Reuters.

Investing.com -- Morgan Stanley (NYSE:MS) has upgraded its rating on Henkel AG (OTC:HENKY) & Co. KGaA (ETR:HNKG) to “equal-weight” from “underweight,” citing signs that the company’s prolonged period of weak organic growth is ending, in a note dated Friday. 

The brokerage raised its price target to €72 from €67, following an 18% year-to-date drop in Henkel shares compared with a 19% rise in the MSCI Europe index.

The upgrade comes after 16 consecutive quarters of volume declines in Henkel’s Consumer Brands division. 

Recent scanner data from the United States and Europe shows sequential improvement, with both regions reporting positive trends in the last four weeks. 

U.S. sales growth in that period was up 3% compared with a flat performance over the last 52 weeks, while European sales rose 4% after a long stretch of declines. 

Market share losses have also narrowed, with some categories such as U.S. hair spray and European laundry detergent showing gains.

Morgan Stanley expects Consumer Brands volumes to grow in the third and fourth quarters of 2025, leading to a stronger second-half performance. 

The brokerage’s forecast for group organic sales growth in 2025 is now 1.7%, slightly above the previous 1.6% estimate, with an adjusted EBIT margin of 15%, up from 14.8% in earlier projections. Earnings per share estimates for 2025 remain at €5.40.

Henkel’s valuation at roughly 12 times next-12-month earnings, near decade lows, and improving sales data limit the risk of further earnings cuts, the report said. 

While Morgan Stanley still expects Henkel to lag household and personal care peers on topline growth over the long term, the current share price reflects a more balanced risk-reward profile.

The analysts said a more positive stance would require evidence of sustained share gains in key consumer categories, improvement in adhesive technologies’ end markets, or effective capital deployment strategies.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.